Skip to main content

Published locations for Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapy

User login

  • Reset your password
  • /content/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll-therapy
  • /fedprac/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll-therapy
  • /hematologynews/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll
  • /oncologypractice/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll
  • /fedprac/avaho/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll
  • /jcomjournal/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll-therapy
  • /hematology-oncology/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll
  • /hematologytimes/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard-cll
  • /b-cell-lymphoma-icymi/article/202488/cll/fixed-duration-venetoclax-obinutuzumab-superior-standard